| Literature DB >> 33364037 |
Shiho Taniguchi1, Yukio Sato1, Naotaka Shimatani1, Yosaku Torii2, Mariko Sekimizu2, Yuki Kamiya3, Kentaro Matsubara3, Hideaki Obara3, Junichi Sasaki1.
Abstract
BACKGROUND: Infected aortic aneurysm secondary to streptococcal toxic shock syndrome caused by Streptococcus pyogenes is uncommon and associated with high mortality. CASEEntities:
Keywords: Cancer; Streptococcus pyogenes; group A streptococcus; infected abdominal aortic aneurysm; streptococcal toxic shock syndrome
Year: 2020 PMID: 33364037 PMCID: PMC7750026 DOI: 10.1002/ams2.617
Source DB: PubMed Journal: Acute Med Surg ISSN: 2052-8817
Laboratory findings on day 1 of admission of a 75‐year‐old man with infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome
| Arterial blood gas analysis (FiO2, 0.4) | Biochemistry | ||||
| pH | 7.480 | Total protein | 5.3 | g/dL | |
| pCO2 | 21.0 | mmHg | Albumin | 2.6 | g/dL |
| pO2 | 120.0 | mmHg | Na | 126.4 | mEq/L |
| HCO3 − | 22.4 | mmol/L | K | 3.9 | mEq/L |
| Anion gap | 15.6 | mmol/L | Cl | 95.0 | mEq/L |
| Lactate | 5.0 | mmol/L | UN | 33.2 | mg/dL |
| Complete blood count | Cr | 2.04 | mg/dL | ||
| WBC | 14.6 | ×103/µL | UA | 7.2 | mg/dL |
| Hb | 12.3 | g/dL | AST | 640 | U/L |
| Platelet | 108 | ×103/µL | ALT | 130 | U/L |
| Coagulation | LD | 1,889 | U/L | ||
| PT | 12.3 | sec | ALP | 202 | U/L |
| APTT | 38.5 | sec | γ‐GTP | 32 | U/L |
| Fibrinogen | 578 | mg/dL | AMY | 212 | U/L |
| FDP | 109.6 | µg/mL | CK | 49,565 | U/L |
| D‐dimer | 71.2 | µg/mL | CRP | 22.31 | mg/dL |
| Endocrine | Procalcitonin | 88.08 | ng/mL | ||
| Glucose | 142 | mg/dL | |||
γ‐GTP, γ‐glutamyl transferase; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AMY, amylase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; Cl, chloride; CK, creatine kinase; Cr, creatinine; CRP, C‐reactive protein; FDP, fibrin degradation products; Hb, hemoglobin; K, potassium; LD, lactate dehydrogenase; Na, sodium; UA, uric acid; UN, urea nitrogen; WBC, white blood cells.
Fig. 1Clinical course of infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome in a 75‐year‐old man, with C‐reactive protein levels (CRP) and treatment. AVP, vasopressin; CHDF, continuous hemodiafiltration; CLDM, clindamycin; FC, fludrocortisone; HC, hydrocortisone; IVIG, i.v. immunoglobulin; NAD, noradrenaline; PCG, penicillin G; PIPC, piperacillin; TAZ, tazobactam; TM, thrombomodulin; VCM, vancomycin.
Fig. 2Enhanced computed tomography images of an infected abdominal aorta aneurysm secondary to streptococcal toxic shock syndrome in a 75‐year‐old man. Images show the aortic aneurysm on day 2 (A) and day 30 (B–D). Arrows (B,D) indicate the increased size of the aneurysm compared to the size noted in the previous computed tomography examination. Arrowheads (C) indicate the enhanced aneurysm wall and saccular appearance of the aneurysm.
Previously published cases of infected aortic aneurysm by Streptococcus pyogenes
| Case | First author | Year of publication | Age/sex | Site of aneurysm | Surgical treatment |
Medical treatment (empiric → directed) | Outcome |
| ||
|---|---|---|---|---|---|---|---|---|---|---|
| Blood | Aneurysm wall | Other | ||||||||
| 1 | Valero | 1992 | 65/M | Infrarenal abd | Resection with bypass graft (1HD) | ABPC/SBT, AZT → NFPC, PCG | Dead (2HD) | + | + | Throat swab + |
| 2 | Sing | 1994 | 58/F | Infrarenal abd | Graft | N/D | Survived | − | N/D | Thrombus in aneurysm + |
| 3 | Bisognano | 1997 | 36/M | Subclavian | Repair with graft (2HD) | N/D | Dead (8HD) | + | + | N/D |
| 4 | Barth | 2000 | 1.5/F | Ascending | Resection with graft (8HD) | CXM, GM → PCG | Survived | + | N/D | Pericardial effusion + |
| 5 | Chen | 2008 | 81/M | Abd | None | N/D | Dead (1HD) | + | N/D | N/D |
| 6 | Leiva | 2009 | 63/F | Thorac‐abd | Resection with bypass graft | VCM, IPM → PCG | Survived | N/D | N/D | N/D |
| 7 | Vallejo | 2011 | 63/F | Thorac‐abd | Resection with graft | VCM, IPM → PCG, DBECPCG | Survived | N/D | N/D | N/D |
| 8 | Hoffman | 2012 | 2/M | Descending | Repair with graft (3HD) | CTRX, ABPC/SBT → CLDM, ABPC | Survived | + | + | N/D |
| 9 | Gardiner | 2013 | 60/M | Infrarenal abd | EVAR and bypass | VCM, CTRX, MNZ → DBECPCG, PIPC/TAZ, AMPC/CVA | Survived | + | N/D | Periaortic mass + |
| 10 | Biswas | 2013 | 58/M | CIA bif | Bypass with graft | AMPC/CVA | Survived | N/D | + | N/D |
| 11 | Tamenishi | 2013 | 63/M | Arch and abd | Bypass (15HD) and resection (22HD) | AMPC, CLDM | Survived | + | N/D | N/D |
| 12 | Cherbanyk | 2017 | 69/F | Infrarenal abd | Resection with graft | PIPC/TAZ → CTRX, CLDM | Survive | + | − | N/D |
| 13 | Someili | 2019 | 70/M | Arch | EVAR | CEZ → PCG | Survive | + | N/D | N/D |
| 14 | Taniguchi | 2020 | 75/M | Abd | Graft | PIPC/TAZ, VCM, CLDM → PCG | Survive | + | − | Sputum + |
−, negative; +, positive; Abd, abdominal aorta; ABPC, ampicillin; AMPC, amoxicillin; Arch, arch aorta; Ascending, ascending aorta; AZT, aztreonam; CEZ, cefazolin; CIA bif, common iliac artery bifurcation; CLDM, clindamycin; CTRX, ceftriaxone; CVA, clavulanate; CXM, cefuroxime; DBECPCG, benzylpenicillin; Descending, descending thoracic aorta; EVAR, endovascular aneurysm repair; F, female; GM, gentamicin; HD, hospital day; IPM, imipenem; M, male; MNZ, metronidazole; N/D, no data; NFPC, nafcillin; PCG, penicillin G; PIPC, piperacillin; SBT, sulbactam; Subclavian, subclavian artery; TAZ, tazobactam; Thorac‐abd, thoracoabdominal aorta; VCM, vancomycin.